Bilateral Nucleus Accumbens Focused Ultrasound Neuromodulation for Stimulant Use Disorder
NCT: NCT06474026 · RECRUITING
Publicidad
Resumen breve
The purpose of this clinical trial is to evaluate the initial safety and efficacy of the ExAblate Model 4000 Type 2.1 surgical device for nucleus accumbens (NAc) neuromodulation in patients with psychostimulant use disorder (PUD).
Fuente oficial
Ver en ClinicalTrials.gov →Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.